Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124372982 | 12437298 | 2 | F | 201605 | 20160626 | 20160606 | 20160707 | EXP | IL-BAXTER-2016BAX028448 | BAXTER | 57.17 | YR | F | Y | 0.00000 | 20160707 | PH | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124372982 | 12437298 | 1 | PS | NACL 0.9% USP | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | WITH PERJETAL, 0.9% 250 ML VIAFLO NP | 15K25E7E,15K25E7E,15K25E7E | 16677 | SOLUTION FOR INFUSION | /wk | |||||||
| 124372982 | 12437298 | 2 | SS | NACL 0.9% USP | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | WITH PACLITAXEL, 0.9% 250 ML VIAFLO NP | 15K25E7E,15K25E7E,15K25E7E | 16677 | SOLUTION FOR INFUSION | /wk | |||||||
| 124372982 | 12437298 | 3 | SS | NACL 0.9% USP | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | WITH PACLITAXEL, 0.9% 250 ML VIAFLO NP | 15K25E7E,15K25E7E,15K25E7E | 16677 | SOLUTION FOR INFUSION | /wk | |||||||
| 124372982 | 12437298 | 4 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 420 MG/ 14 ML | H0122B02,H0135B02 | 0 | /wk | ||||||||
| 124372982 | 12437298 | 5 | SS | TAXOL | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 100 MG/16.7 ML | 15C02KI,15H21NM,15C02KI | 0 | /wk | ||||||||
| 124372982 | 12437298 | 6 | SS | TAXOL | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 30 MG/5 ML | 15C02KI,15H21NM,15C02KI | 0 | /wk | ||||||||
| 124372982 | 12437298 | 7 | SS | TAXOL | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 100 MG/16.7 ML | 15C02KI,15H21NM,15C02KI | 0 | /wk | ||||||||
| 124372982 | 12437298 | 8 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | U | 0 | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124372982 | 12437298 | 1 | Medication dilution |
| 124372982 | 12437298 | 4 | Breast cancer |
| 124372982 | 12437298 | 5 | Breast cancer |
| 124372982 | 12437298 | 8 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124372982 | 12437298 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124372982 | 12437298 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124372982 | 12437298 | 1 | 20160518 | 20160518 | 0 | |
| 124372982 | 12437298 | 2 | 20160518 | 20160518 | 0 | |
| 124372982 | 12437298 | 3 | 20160525 | 20160525 | 0 | |
| 124372982 | 12437298 | 4 | 20160518 | 20160518 | 0 | |
| 124372982 | 12437298 | 5 | 20160518 | 20160518 | 0 | |
| 124372982 | 12437298 | 6 | 20160525 | 20160525 | 0 | |
| 124372982 | 12437298 | 7 | 20160525 | 20160525 | 0 |